SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Expensive Performer

1747.8000 43.50 (2.55%)

NSE Mar 18, 2025 15:31 PM

26.91% Gain from 52W Low

Volume: 2.7M

Sun Pharmaceutical Industries Ltd.

10 Feb 2023

1747.80

2.55%

Company Update

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release relating to US FDA approval for generic Lenalidomide capsules.

More from Sun Pharmaceutical Industries Ltd.

Recommended

Five stocks to buy from analysts this week - March 18, 2025

The Baseline | 18 Mar 2025, 05:17PM

Market closes higher, HUL gets approval to acquire Minimalist's parent firm for Rs 2,670 crore

Trendlyne Marketwatch | 18 Mar 2025, 04:04PM

Change is hard, and some Indian pharma companies are embracing it better than others